Home
>
National Drug Code (NDC)
>
Clopidogrel
Clopidogrel - 55648-315-04 - (Clopidogrel)
Drug Information of Clopidogrel
| Product NDC: | 55648-315 |
| Proprietary Name: | Clopidogrel |
| Non Proprietary Name: | Clopidogrel |
| Active Ingredient(s): | 300 mg/1 & nbsp; Clopidogrel |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Clopidogrel
| Product NDC: | 55648-315 |
| Labeler Name: | Wockhardt Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202266 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121113 |
Package Information of Clopidogrel
| Package NDC: | 55648-315-04 |
| Package Description: | 10 BLISTER PACK in 1 CARTON (55648-315-04) > 10 TABLET, FILM COATED in 1 BLISTER PACK |
NDC Information of Clopidogrel
| NDC Code | 55648-315-04 |
| Proprietary Name | Clopidogrel |
| Package Description | 10 BLISTER PACK in 1 CARTON (55648-315-04) > 10 TABLET, FILM COATED in 1 BLISTER PACK |
| Product NDC | 55648-315 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Clopidogrel |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20121113 |
| Marketing Category Name | ANDA |
| Labeler Name | Wockhardt Limited |
| Substance Name | CLOPIDOGREL BISULFATE |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA] |
